Private company

ACTAVIA LIFE SCIENCES, INC.

Last updated Oct 16, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersNV
  • Incorporated inNV2
  • Business address5 Penn Plaza, 19Th Floor, #1954, New York, Ny 100012
  • Filer categoryNon-accelerated filer, Smaller reporting company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2018

-131.3%Return on equity3
-$2.6MFree cash flow4

Financial statements

Revenue56$0 in 2018
02017: $0$020172018: $0$02018
Gross profit6$0 in 2018
02017: $0$020172018: $0$02018
Operating income64-$4.1M in 2018−10% since 2017
-$6.0M-$4.0M-$2.0M02017: -$4.5M-$4.5M20172018: -$4.1M-$4.1M2018−10%
Net income64-$4.1M in 2018−8% since 2017
-$6.0M-$4.0M-$2.0M02017: -$4.4M-$4.4M20172018: -$4.1M-$4.1M2018−8%
Fiscal year20172018
Revenue$05$06
Cost of revenue$06$06
Gross profit$06$06
Research and development$1.6M6$324.6K4
Operating income-$4.5M6-$4.1M4
Interest$2.3K4
Income tax$06$2.1K4
Net income-$4.4M6-$4.1M4
Earnings per share
Earnings per share (diluted)

Compare ACTAVIA LIFE SCIENCES, INC. with another company

Former names

  • Rasna Therapeutics Inc.Sep 27, 2016 to Aug 14, 20232
  • Active With Me Inc.Sep 11, 2013 to Sep 26, 20162

Recent filings

  1. May 20, 202410-Q QUARTERLY REPORT
  2. Apr 10, 20248-K CURRENT REPORT
  3. Feb 16, 202410-Q QUARTERLY REPORT
  4. Jan 5, 202410-K ANNUAL REPORT
  5. Oct 26, 20238-K CURRENT REPORT
  6. Aug 14, 202310-Q QUARTERLY REPORT
  7. May 15, 202310-Q QUARTERLY REPORT
  8. Mar 2, 202310-Q QUARTERLY REPORT
  9. Feb 9, 202310-K ANNUAL REPORT
  10. Jan 23, 20238-K CURRENT REPORT
  11. Dec 20, 20228-K CURRENT REPORT
  12. Aug 22, 202210-Q QUARTERLY REPORT
  13. Jun 21, 202210-Q QUARTERLY REPORT
  14. Jun 16, 202210-Q QUARTERLY REPORT
  15. Jun 10, 202210-K/A AMENDMENT NO.1 TO FORM 10-K

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1